Mirae Asset Global Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,787
Closed -$1.26M 1730
2024
Q1
$1.26M Sell
12,787
-1,220
-9% -$109K ﹤0.01% 1414
2023
Q4
$1.53M Buy
14,007
+382
+3% +$39.5K ﹤0.01% 1386
2023
Q3
$1.37M Hold
13,625
﹤0.01% 1367
2023
Q2
$1.85M Buy
13,625
+838
+7% +$102K ﹤0.01% 1250
2023
Q1
$1.33M Hold
12,787
﹤0.01% 1400
2022
Q4
$1.13M Buy
12,787
+645
+5% +$53.5K ﹤0.01% 1419
2022
Q3
$973K Buy
+12,142
New +$1.15M ﹤0.01% 1500

Other funds holding CNMD

Mirae Asset Global Investments's CNMD Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of CONMED (CNMD) in Q2 2024, closing a stake of 12,787 shares — an estimated $1.26M sold.

Mirae Asset Global Investments first reported a position in CNMD in Q3 2022 and held it in 7 quarters. The position peaked at $1.85M in Q2 2023. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 12,787 CONMED shares in Q2 2024, an estimated $1.26M.
  • Mirae Asset Global Investments first reported a position in CONMED in Q3 2022 and held it in 7 quarters.
  • Mirae Asset Global Investments's CONMED position peaked at $1.85M in Q2 2023.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.